0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Drug Protection Reagents Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-15K19268
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Drug Protection Reagents Market Research Report 2025
BUY CHAPTERS

Global Peptide Drug Protection Reagents Market Research Report 2025

Code: QYRE-Auto-15K19268
Report
April 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peptide Drug Protection Reagents Market Size

The global market for Peptide Drug Protection Reagents was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 201 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Peptide Drug Protection Reagents Market

Peptide Drug Protection Reagents Market

Peptide drug protection reagents are a class of chemical agents used to prevent peptide drugs from degradation during synthesis, storage, and in vivo delivery. These reagents work by modifying specific functional groups of peptides, such as amino, carboxyl, or hydroxyl groups, to protect them from enzymatic hydrolysis or oxidation, thereby enhancing their stability and bioavailability. Common peptide protection reagents include acyl protecting groups (e.g., Boc, Fmoc), ester protecting groups (e.g., OMe, OtBu), and thioether protecting groups (e.g., Acm, Trt). The proper selection and application of protection reagents in peptide drug development can optimize chemical stability, improve efficacy, and minimize potential side effects. Therefore, these reagents play a crucial role in the fields of biopharmaceuticals and chemical synthesis.
North American market for Peptide Drug Protection Reagents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Drug Protection Reagents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peptide Drug Protection Reagents include Merck, Iris Biotech, Curia Global, Suzhou Highfine Biotech, GL Biochem, GenChem & GenPharm, Ningxia Jinxiang Pharmaceutical Chemical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peptide Drug Protection Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Drug Protection Reagents.
The Peptide Drug Protection Reagents market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Drug Protection Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Drug Protection Reagents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Drug Protection Reagents Market Report

Report Metric Details
Report Name Peptide Drug Protection Reagents Market
Accounted market size in year US$ 146 million
Forecasted market size in 2031 US$ 201 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Fmoc Series
  • Boc Series
  • Others
by Application
  • Pharmaceuticals
  • Laboratory
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Iris Biotech, Curia Global, Suzhou Highfine Biotech, GL Biochem, GenChem & GenPharm, Ningxia Jinxiang Pharmaceutical Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peptide Drug Protection Reagents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Peptide Drug Protection Reagents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Peptide Drug Protection Reagents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Drug Protection Reagents Market growing?

Ans: The Peptide Drug Protection Reagents Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Peptide Drug Protection Reagents Market size in 2031?

Ans: The Peptide Drug Protection Reagents Market size in 2031 will be US$ 201 million.

Who are the main players in the Peptide Drug Protection Reagents Market report?

Ans: The main players in the Peptide Drug Protection Reagents Market are Merck, Iris Biotech, Curia Global, Suzhou Highfine Biotech, GL Biochem, GenChem & GenPharm, Ningxia Jinxiang Pharmaceutical Chemical

What are the Application segmentation covered in the Peptide Drug Protection Reagents Market report?

Ans: The Applications covered in the Peptide Drug Protection Reagents Market report are Pharmaceuticals, Laboratory

What are the Type segmentation covered in the Peptide Drug Protection Reagents Market report?

Ans: The Types covered in the Peptide Drug Protection Reagents Market report are Fmoc Series, Boc Series, Others

1 Peptide Drug Protection Reagents Market Overview
1.1 Product Definition
1.2 Peptide Drug Protection Reagents by Type
1.2.1 Global Peptide Drug Protection Reagents Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Fmoc Series
1.2.3 Boc Series
1.2.4 Others
1.3 Peptide Drug Protection Reagents by Application
1.3.1 Global Peptide Drug Protection Reagents Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Laboratory
1.4 Global Market Growth Prospects
1.4.1 Global Peptide Drug Protection Reagents Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Peptide Drug Protection Reagents Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Peptide Drug Protection Reagents Production Estimates and Forecasts (2020-2031)
1.4.4 Global Peptide Drug Protection Reagents Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Peptide Drug Protection Reagents Production Market Share by Manufacturers (2020-2025)
2.2 Global Peptide Drug Protection Reagents Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Peptide Drug Protection Reagents, Industry Ranking, 2023 VS 2024
2.4 Global Peptide Drug Protection Reagents Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Peptide Drug Protection Reagents Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Peptide Drug Protection Reagents, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Peptide Drug Protection Reagents, Product Offered and Application
2.8 Global Key Manufacturers of Peptide Drug Protection Reagents, Date of Enter into This Industry
2.9 Peptide Drug Protection Reagents Market Competitive Situation and Trends
2.9.1 Peptide Drug Protection Reagents Market Concentration Rate
2.9.2 Global 5 and 10 Largest Peptide Drug Protection Reagents Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Peptide Drug Protection Reagents Production by Region
3.1 Global Peptide Drug Protection Reagents Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Peptide Drug Protection Reagents Production Value by Region (2020-2031)
3.2.1 Global Peptide Drug Protection Reagents Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Peptide Drug Protection Reagents by Region (2026-2031)
3.3 Global Peptide Drug Protection Reagents Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Peptide Drug Protection Reagents Production Volume by Region (2020-2031)
3.4.1 Global Peptide Drug Protection Reagents Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Peptide Drug Protection Reagents by Region (2026-2031)
3.5 Global Peptide Drug Protection Reagents Market Price Analysis by Region (2020-2025)
3.6 Global Peptide Drug Protection Reagents Production and Value, Year-over-Year Growth
3.6.1 North America Peptide Drug Protection Reagents Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Peptide Drug Protection Reagents Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Peptide Drug Protection Reagents Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Peptide Drug Protection Reagents Production Value Estimates and Forecasts (2020-2031)
4 Peptide Drug Protection Reagents Consumption by Region
4.1 Global Peptide Drug Protection Reagents Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Peptide Drug Protection Reagents Consumption by Region (2020-2031)
4.2.1 Global Peptide Drug Protection Reagents Consumption by Region (2020-2025)
4.2.2 Global Peptide Drug Protection Reagents Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Peptide Drug Protection Reagents Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Peptide Drug Protection Reagents Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Peptide Drug Protection Reagents Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Peptide Drug Protection Reagents Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Peptide Drug Protection Reagents Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Peptide Drug Protection Reagents Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Peptide Drug Protection Reagents Production by Type (2020-2031)
5.1.1 Global Peptide Drug Protection Reagents Production by Type (2020-2025)
5.1.2 Global Peptide Drug Protection Reagents Production by Type (2026-2031)
5.1.3 Global Peptide Drug Protection Reagents Production Market Share by Type (2020-2031)
5.2 Global Peptide Drug Protection Reagents Production Value by Type (2020-2031)
5.2.1 Global Peptide Drug Protection Reagents Production Value by Type (2020-2025)
5.2.2 Global Peptide Drug Protection Reagents Production Value by Type (2026-2031)
5.2.3 Global Peptide Drug Protection Reagents Production Value Market Share by Type (2020-2031)
5.3 Global Peptide Drug Protection Reagents Price by Type (2020-2031)
6 Segment by Application
6.1 Global Peptide Drug Protection Reagents Production by Application (2020-2031)
6.1.1 Global Peptide Drug Protection Reagents Production by Application (2020-2025)
6.1.2 Global Peptide Drug Protection Reagents Production by Application (2026-2031)
6.1.3 Global Peptide Drug Protection Reagents Production Market Share by Application (2020-2031)
6.2 Global Peptide Drug Protection Reagents Production Value by Application (2020-2031)
6.2.1 Global Peptide Drug Protection Reagents Production Value by Application (2020-2025)
6.2.2 Global Peptide Drug Protection Reagents Production Value by Application (2026-2031)
6.2.3 Global Peptide Drug Protection Reagents Production Value Market Share by Application (2020-2031)
6.3 Global Peptide Drug Protection Reagents Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Merck
7.1.1 Merck Peptide Drug Protection Reagents Company Information
7.1.2 Merck Peptide Drug Protection Reagents Product Portfolio
7.1.3 Merck Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Merck Main Business and Markets Served
7.1.5 Merck Recent Developments/Updates
7.2 Iris Biotech
7.2.1 Iris Biotech Peptide Drug Protection Reagents Company Information
7.2.2 Iris Biotech Peptide Drug Protection Reagents Product Portfolio
7.2.3 Iris Biotech Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Iris Biotech Main Business and Markets Served
7.2.5 Iris Biotech Recent Developments/Updates
7.3 Curia Global
7.3.1 Curia Global Peptide Drug Protection Reagents Company Information
7.3.2 Curia Global Peptide Drug Protection Reagents Product Portfolio
7.3.3 Curia Global Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Curia Global Main Business and Markets Served
7.3.5 Curia Global Recent Developments/Updates
7.4 Suzhou Highfine Biotech
7.4.1 Suzhou Highfine Biotech Peptide Drug Protection Reagents Company Information
7.4.2 Suzhou Highfine Biotech Peptide Drug Protection Reagents Product Portfolio
7.4.3 Suzhou Highfine Biotech Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Suzhou Highfine Biotech Main Business and Markets Served
7.4.5 Suzhou Highfine Biotech Recent Developments/Updates
7.5 GL Biochem
7.5.1 GL Biochem Peptide Drug Protection Reagents Company Information
7.5.2 GL Biochem Peptide Drug Protection Reagents Product Portfolio
7.5.3 GL Biochem Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.5.4 GL Biochem Main Business and Markets Served
7.5.5 GL Biochem Recent Developments/Updates
7.6 GenChem & GenPharm
7.6.1 GenChem & GenPharm Peptide Drug Protection Reagents Company Information
7.6.2 GenChem & GenPharm Peptide Drug Protection Reagents Product Portfolio
7.6.3 GenChem & GenPharm Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.6.4 GenChem & GenPharm Main Business and Markets Served
7.6.5 GenChem & GenPharm Recent Developments/Updates
7.7 Ningxia Jinxiang Pharmaceutical Chemical
7.7.1 Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Protection Reagents Company Information
7.7.2 Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Protection Reagents Product Portfolio
7.7.3 Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Protection Reagents Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Ningxia Jinxiang Pharmaceutical Chemical Main Business and Markets Served
7.7.5 Ningxia Jinxiang Pharmaceutical Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Peptide Drug Protection Reagents Industry Chain Analysis
8.2 Peptide Drug Protection Reagents Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Peptide Drug Protection Reagents Production Mode & Process Analysis
8.4 Peptide Drug Protection Reagents Sales and Marketing
8.4.1 Peptide Drug Protection Reagents Sales Channels
8.4.2 Peptide Drug Protection Reagents Distributors
8.5 Peptide Drug Protection Reagents Customer Analysis
9 Peptide Drug Protection Reagents Market Dynamics
9.1 Peptide Drug Protection Reagents Industry Trends
9.2 Peptide Drug Protection Reagents Market Drivers
9.3 Peptide Drug Protection Reagents Market Challenges
9.4 Peptide Drug Protection Reagents Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Peptide Drug Protection Reagents Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Peptide Drug Protection Reagents Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Peptide Drug Protection Reagents Production Capacity (kg) by Manufacturers in 2024
 Table 4. Global Peptide Drug Protection Reagents Production by Manufacturers (2020-2025) & (kg)
 Table 5. Global Peptide Drug Protection Reagents Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Peptide Drug Protection Reagents Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Peptide Drug Protection Reagents Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Peptide Drug Protection Reagents, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Peptide Drug Protection Reagents as of 2024)
 Table 10. Global Market Peptide Drug Protection Reagents Average Price by Manufacturers (US$/g) & (2020-2025)
 Table 11. Global Key Manufacturers of Peptide Drug Protection Reagents, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Peptide Drug Protection Reagents, Product Offered and Application
 Table 13. Global Key Manufacturers of Peptide Drug Protection Reagents, Date of Enter into This Industry
 Table 14. Global Peptide Drug Protection Reagents Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peptide Drug Protection Reagents Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Peptide Drug Protection Reagents Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Peptide Drug Protection Reagents Production Value Market Share by Region (2020-2025)
 Table 19. Global Peptide Drug Protection Reagents Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Peptide Drug Protection Reagents Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Peptide Drug Protection Reagents Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
 Table 22. Global Peptide Drug Protection Reagents Production (kg) by Region (2020-2025)
 Table 23. Global Peptide Drug Protection Reagents Production Market Share by Region (2020-2025)
 Table 24. Global Peptide Drug Protection Reagents Production (kg) Forecast by Region (2026-2031)
 Table 25. Global Peptide Drug Protection Reagents Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Peptide Drug Protection Reagents Market Average Price (US$/g) by Region (2020-2025)
 Table 27. Global Peptide Drug Protection Reagents Market Average Price (US$/g) by Region (2026-2031)
 Table 28. Global Peptide Drug Protection Reagents Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
 Table 29. Global Peptide Drug Protection Reagents Consumption by Region (2020-2025) & (kg)
 Table 30. Global Peptide Drug Protection Reagents Consumption Market Share by Region (2020-2025)
 Table 31. Global Peptide Drug Protection Reagents Forecasted Consumption by Region (2026-2031) & (kg)
 Table 32. Global Peptide Drug Protection Reagents Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Peptide Drug Protection Reagents Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 34. North America Peptide Drug Protection Reagents Consumption by Country (2020-2025) & (kg)
 Table 35. North America Peptide Drug Protection Reagents Consumption by Country (2026-2031) & (kg)
 Table 36. Europe Peptide Drug Protection Reagents Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 37. Europe Peptide Drug Protection Reagents Consumption by Country (2020-2025) & (kg)
 Table 38. Europe Peptide Drug Protection Reagents Consumption by Country (2026-2031) & (kg)
 Table 39. Asia Pacific Peptide Drug Protection Reagents Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
 Table 40. Asia Pacific Peptide Drug Protection Reagents Consumption by Region (2020-2025) & (kg)
 Table 41. Asia Pacific Peptide Drug Protection Reagents Consumption by Region (2026-2031) & (kg)
 Table 42. Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 43. Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption by Country (2020-2025) & (kg)
 Table 44. Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption by Country (2026-2031) & (kg)
 Table 45. Global Peptide Drug Protection Reagents Production (kg) by Type (2020-2025)
 Table 46. Global Peptide Drug Protection Reagents Production (kg) by Type (2026-2031)
 Table 47. Global Peptide Drug Protection Reagents Production Market Share by Type (2020-2025)
 Table 48. Global Peptide Drug Protection Reagents Production Market Share by Type (2026-2031)
 Table 49. Global Peptide Drug Protection Reagents Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Peptide Drug Protection Reagents Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Peptide Drug Protection Reagents Production Value Market Share by Type (2020-2025)
 Table 52. Global Peptide Drug Protection Reagents Production Value Market Share by Type (2026-2031)
 Table 53. Global Peptide Drug Protection Reagents Price (US$/g) by Type (2020-2025)
 Table 54. Global Peptide Drug Protection Reagents Price (US$/g) by Type (2026-2031)
 Table 55. Global Peptide Drug Protection Reagents Production (kg) by Application (2020-2025)
 Table 56. Global Peptide Drug Protection Reagents Production (kg) by Application (2026-2031)
 Table 57. Global Peptide Drug Protection Reagents Production Market Share by Application (2020-2025)
 Table 58. Global Peptide Drug Protection Reagents Production Market Share by Application (2026-2031)
 Table 59. Global Peptide Drug Protection Reagents Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Peptide Drug Protection Reagents Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Peptide Drug Protection Reagents Production Value Market Share by Application (2020-2025)
 Table 62. Global Peptide Drug Protection Reagents Production Value Market Share by Application (2026-2031)
 Table 63. Global Peptide Drug Protection Reagents Price (US$/g) by Application (2020-2025)
 Table 64. Global Peptide Drug Protection Reagents Price (US$/g) by Application (2026-2031)
 Table 65. Merck Peptide Drug Protection Reagents Company Information
 Table 66. Merck Peptide Drug Protection Reagents Specification and Application
 Table 67. Merck Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 68. Merck Main Business and Markets Served
 Table 69. Merck Recent Developments/Updates
 Table 70. Iris Biotech Peptide Drug Protection Reagents Company Information
 Table 71. Iris Biotech Peptide Drug Protection Reagents Specification and Application
 Table 72. Iris Biotech Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Iris Biotech Main Business and Markets Served
 Table 74. Iris Biotech Recent Developments/Updates
 Table 75. Curia Global Peptide Drug Protection Reagents Company Information
 Table 76. Curia Global Peptide Drug Protection Reagents Specification and Application
 Table 77. Curia Global Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Curia Global Main Business and Markets Served
 Table 79. Curia Global Recent Developments/Updates
 Table 80. Suzhou Highfine Biotech Peptide Drug Protection Reagents Company Information
 Table 81. Suzhou Highfine Biotech Peptide Drug Protection Reagents Specification and Application
 Table 82. Suzhou Highfine Biotech Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Suzhou Highfine Biotech Main Business and Markets Served
 Table 84. Suzhou Highfine Biotech Recent Developments/Updates
 Table 85. GL Biochem Peptide Drug Protection Reagents Company Information
 Table 86. GL Biochem Peptide Drug Protection Reagents Specification and Application
 Table 87. GL Biochem Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. GL Biochem Main Business and Markets Served
 Table 89. GL Biochem Recent Developments/Updates
 Table 90. GenChem & GenPharm Peptide Drug Protection Reagents Company Information
 Table 91. GenChem & GenPharm Peptide Drug Protection Reagents Specification and Application
 Table 92. GenChem & GenPharm Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. GenChem & GenPharm Main Business and Markets Served
 Table 94. GenChem & GenPharm Recent Developments/Updates
 Table 95. Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Protection Reagents Company Information
 Table 96. Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Protection Reagents Specification and Application
 Table 97. Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Protection Reagents Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. Ningxia Jinxiang Pharmaceutical Chemical Main Business and Markets Served
 Table 99. Ningxia Jinxiang Pharmaceutical Chemical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Peptide Drug Protection Reagents Distributors List
 Table 103. Peptide Drug Protection Reagents Customers List
 Table 104. Peptide Drug Protection Reagents Market Trends
 Table 105. Peptide Drug Protection Reagents Market Drivers
 Table 106. Peptide Drug Protection Reagents Market Challenges
 Table 107. Peptide Drug Protection Reagents Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peptide Drug Protection Reagents
 Figure 2. Global Peptide Drug Protection Reagents Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Peptide Drug Protection Reagents Market Share by Type: 2024 VS 2031
 Figure 4. Fmoc Series Product Picture
 Figure 5. Boc Series Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Peptide Drug Protection Reagents Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Peptide Drug Protection Reagents Market Share by Application: 2024 VS 2031
 Figure 9. Pharmaceuticals
 Figure 10. Laboratory
 Figure 11. Global Peptide Drug Protection Reagents Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Peptide Drug Protection Reagents Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Peptide Drug Protection Reagents Production Capacity (kg) & (2020-2031)
 Figure 14. Global Peptide Drug Protection Reagents Production (kg) & (2020-2031)
 Figure 15. Global Peptide Drug Protection Reagents Average Price (US$/g) & (2020-2031)
 Figure 16. Peptide Drug Protection Reagents Report Years Considered
 Figure 17. Peptide Drug Protection Reagents Production Share by Manufacturers in 2024
 Figure 18. Global Peptide Drug Protection Reagents Production Value Share by Manufacturers (2024)
 Figure 19. Peptide Drug Protection Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Peptide Drug Protection Reagents Revenue in 2024
 Figure 21. Global Peptide Drug Protection Reagents Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Peptide Drug Protection Reagents Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Peptide Drug Protection Reagents Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
 Figure 24. Global Peptide Drug Protection Reagents Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Peptide Drug Protection Reagents Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Peptide Drug Protection Reagents Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Peptide Drug Protection Reagents Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan Peptide Drug Protection Reagents Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global Peptide Drug Protection Reagents Consumption by Region: 2020 VS 2024 VS 2031 (kg)
 Figure 30. Global Peptide Drug Protection Reagents Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 32. North America Peptide Drug Protection Reagents Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 34. Canada Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 35. Europe Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 36. Europe Peptide Drug Protection Reagents Consumption Market Share by Country (2020-2031)
 Figure 37. Germany Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 38. France Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 39. U.K. Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 40. Italy Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 41. Russia Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 42. Asia Pacific Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 43. Asia Pacific Peptide Drug Protection Reagents Consumption Market Share by Region (2020-2031)
 Figure 44. China Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 45. Japan Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 46. South Korea Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 47. China Taiwan Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 48. Southeast Asia Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 49. India Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 50. Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 51. Latin America, Middle East & Africa Peptide Drug Protection Reagents Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 53. Brazil Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 54. Turkey Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 55. GCC Countries Peptide Drug Protection Reagents Consumption and Growth Rate (2020-2031) & (kg)
 Figure 56. Global Production Market Share of Peptide Drug Protection Reagents by Type (2020-2031)
 Figure 57. Global Production Value Market Share of Peptide Drug Protection Reagents by Type (2020-2031)
 Figure 58. Global Peptide Drug Protection Reagents Price (US$/g) by Type (2020-2031)
 Figure 59. Global Production Market Share of Peptide Drug Protection Reagents by Application (2020-2031)
 Figure 60. Global Production Value Market Share of Peptide Drug Protection Reagents by Application (2020-2031)
 Figure 61. Global Peptide Drug Protection Reagents Price (US$/g) by Application (2020-2031)
 Figure 62. Peptide Drug Protection Reagents Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc